Literature DB >> 9616499

An overweight woman with galactorrhoea.

W S Chow1, K S Lam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616499      PMCID: PMC2360815          DOI: 10.1136/pgmj.74.868.121

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  An assessment of the concentration of acetic acid and propionic acid derivatives of 3,5,3'-triiodothyronine in human serum.

Authors:  Y Nakamura; I J Chopra; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1978-01       Impact factor: 5.958

2.  Triac (3,5,3'-triiodothyroacetic acid) partially inhibits the thyrotropin response to synthetic thyrotropin-releasing hormone in normal and thyroidectomized hypothyroid patients.

Authors:  G Medeiros-Neto; W G Kallas; M Knobel; H Cavaliere; E Mattar
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

3.  Comparison of the metabolic and endocrine effects of 3,5,3'-triiodothyroacetic acid and thyroxine.

Authors:  D Bracco; O Morin; Y Schutz; H Liang; E Jéquier; A G Burger
Journal:  J Clin Endocrinol Metab       Date:  1993-07       Impact factor: 5.958

4.  Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells.

Authors:  M E Everts; T J Visser; E P Moerings; R Docter; H van Toor; A M Tempelaars; M de Jong; E P Krenning; G Hennemann
Journal:  Endocrinology       Date:  1994-12       Impact factor: 4.736

5.  Triac reduces serum TSH without decreasing alpha and beta TSH messenger RNAs.

Authors:  C J Mirell; M Yanagisawa; J M Hershman
Journal:  Horm Metab Res       Date:  1989-03       Impact factor: 2.936

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.